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ABSTRACT 
JRK’s Anti-coff was evaluated for blood purification benefit by phagocytosis.  and surprisingly we found that Aniscochilus carnosus showed muco-
constriction benefit, while Ocimum sanctum and Adathoda vasica showed mucolytic property. The clinical implication of the above therapeutic 
benefits is discussed in detail in the article from the context of Siddha system of medicine. The findings are discussed in the article. 
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INTRODUCTION  
JRK’s Anti-coff is the first Siddha proprietary medicine 
formulated to address both the underlying cause and the 
symptom of the most common medical problem i.e., 
continuous /short intermittent cough of infectious or non-
infectious etiology.  
The herbs used in the formulation are known to enhance 
phagocytosis and thus could eliminates/attenuate the 
pathogens or antigen or allergens responsible for the 
problem. We have scientifically proved the effect of JRK’s 
Anti-coff in boosting phagocytosis against wide range of 
pathogens 1.  
The science of blood purification otherwise called as the 
removal of antigens from the blood and its importance in the 
management of cough and early phase of allergic or 
infectious upper respiratory tract problems, JRK’s Research 
and Pharmaceuticals is the first company to highlight and 
establish the above treatment strategy through intense 
research.  
We have continued our quest to understand how the 
different herbs in JRK’s Anti-coff can change or modify or 
lyse the mucous that is secreted during cough and upper 
respiratory tract infections.  
Mucolytic agents are widely used but the importance of 
muco-constrictors along with mucolytic agents in the 
treatment of cough and upper respiratory infection is less 
known and studied 2. Further whether the herbs can be as 
effective as N-acetyl cysteine to lyse the mucous or would 
constrict the mucous to offer relief is not clearly studied.  
In the present paper we have studied the effect of different 
herbs of JRK’s Anti- coff for muco- constriction and 
mucolysis and have established that certain herbs have 
mucolytic property while some herbs have caused mucous 
constriction. The scientific importance and the medical 
interpretation of the above are presented in the paper. This 
is the first research work to show certain herbs can indeed 
constrict mucous. 
METHODS 
Formulation details of JRK’s Anti-coff 
JRK’s Anti- Coff is formulated with following herbs such as 
Aniscochilus carnosus , Leucas aspera , Ocimum sanctum , 
Solanum trilobatum , Acalypha indica  Adathoda vasica  
Extraction of the plant materials 
All the above herbs were extracted individually in water by 
boiling process. The solvent to solute ratio was 1:10. It was 
filtered and the filtrate was stored in refrigerator until use. 
Preparation of phosphate buffer solution 
The phosphate buffer with pH 7 was prepared by mixing 50 
ml of 0.2M dihydrogen phosphate potassium with 29.1 ml of 
2N sodium hydroxide and diluted with carbon-free water. 
Finally the pH was adjusted.  
Preparation of egg white 
Three day old duck’s egg was procured and the egg white 
was carefully separated from yolk.  The egg white thus 
obtained was mixed with phosphate buffer solution at the 
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ratio of 20: 80 and then stirred to achieve a homogeneous 
solution.  
Mucolytic study  
The egg white solution was divided accordingly and the 
extracts of all the plants were incorporated into the egg 
white solution separately at 3 different concentrations such 
as 1, 2 and 3 %. The above experimental set up in triplicate 
was maintained for 15 minutes. Then the solution was tested 
for its viscosity using Brookfield viscometer. Untreated egg 
albumin in phosphate buffer (20:80) was kept as negative 
control and N- acetyl cysteine treatment was used as positive 
control. Difference in the viscosity of the test was compared 
with positive and negative control accordingly the 
interpretation was made as mucolysis or muco constriction 3.  
RESULTS 
The medicinal plants such as Ocimum sanctum and Adathoda 
vasica showed strong mucolytic activity which was 
comparable to the activity of N-acetyl cysteine. Interestingly 
Anisochilus carnosus showed strong muco constriction 
activity. The medicinal plants such as Leucas aspera, 
Solanum trilobatum and Acalypha indica did not show any 
mucolytic or muco constriction activity. Table- 1 
   
Table 1: Mucolytic and muco constriction activity of different herbs of JRK’s Anti- coff 
Herbs 
Concentration 
(%) 
The viscosity of the egg white Solution (cPoise) 
12 rpm 30 rpm 60 rpm 
Aniscochilus carnosus 
1 40,80 36,12 31,21 
2 41,19 37,14 32,18 
3 42,02 38,09 33,11 
Leucas aspera 
1 32,50 26,22 24,65 
2 31,30 25,22 23,73 
3 30,18 24,14 22,88 
Ocimum sanctum 
1 21,22 18,90 17,10 
2 20,24 18,05 17,00 
3 19,01 17,56 16,32 
Solanum trilbatum 
1 31,12 29,02 28,09 
2 29,15 28,81 27,22 
3 29,00 28,06 26,99 
Acalypha indica 
1 31,20 30,11, 29,98 
2 30,25 29,00 28,01 
3 29,19 28,00 27,18 
Adathoda vasica 
1 18,99 17,25 16,01 
2 17,02 16,81 15,12 
3 15,99 14,11 13,08 
Negative control 31,70 28,07 26,11 
N- acetyl cysteine treatment (0.5%) 14,50 11,50 10,80 
 
 
DISCUSSION  
The present study has thrown an array of interesting facets 
of the medicinal plants and their possible divergent 
therapeutics. Mucolytic substances are exploited greatly for 
the treatment of cough and upper respiratory tract infection 
(URTI). Several plants have shown mucolytic activity. But 
this is the first study to the best of our understanding where 
a plant showing muco constriction activity.  
Mucus is a slippery polymer produced by the cells found in 
the mucous glands which contain both serous and mucous 
cells. Mucous is a viscous colloid containing inorganic 
salts, antiseptic enzymes (such 
as lysozymes), immunoglobulins, and glycoproteins such 
as lactoferrin and mucins, which are produced by goblet 
cells in the mucous membranes and submucosal glands 4.  
Although mucous serves a protective activity but during 
allergic and infectious conditions the abundant secretion of 
mucous will cause obstruction and discomfort to the 
patients. Therefore removal of the mucous is necessary. 
Mucolytic agents liquefy or dissolve the mucous and thereby 
aid their removal 5, 6. However the underlying causes that 
might trigger the continuous secretion of mucous needs to 
be addressed for permanent solution.  
The use of muco constrictors are less known. However the 
nasal vein constrictors such as Xylometazoline is used as a 
decongesting agent during acute inflammatory nasal 
congestion 7.  
 The plant Aniscochilus carnosus has exhibited muco 
constrictor property. Whether the above property can be 
extrapolated to the decongesting effect needs further 
research. However such benefit cannot be ruled out.  
Considering the wide acceptance and clinical approval of 
JRK’s anti-coff by the vaidyas of Indian systems of medicine, 
we presume that both the mucolytic and the muco-
constrictor herbs may be complementing with each other 
instead of conflicting with each other and thereby offers the 
desired therapeutic benefit. The muco -constriction may be 
at the root level prevents the mucous secretion and the 
residual mucous is lysed by the herbs which has got 
mucolytic property. It is also possible that the muco –
constrictor herb may sort and isolate the mucous for the 
lysis process to take place effectively.  
The effect of certain plants in JRK’s Anti-coff in boosting 
phagocytosis may also be linked with the muco-constrictor 
and mucolytic effect of other herbs in the formulation. The 
muco constrictor may thicken the mucous thereby the 
pathogens/allergens are packed effectively and thus their 
removal is achieved by the subsequent activity of the 
mucolytic agents. 
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The clinical acceptance of JRK’s Anti-coff  by the vaidyas of 
Indian systems of medicine along with the reports on proven 
clinical efficacy of JRK’s Anti-coff in the treatment of cough 
and UTI strongly suggests that multiple mechanisms of 
action of different herbs in the drug is highly possible.  
The blood purification effect of JRK’s Anti- coff has been 
already established through invitro studies and in the light of 
the present study we believe that JRK’s Anti- coff may be the 
first siddha drug to have multiple mechanisms such as blood 
purification, mucolysis, muco constriction benefits for the 
management of cough and UTI.   
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